Repeated oral Toxicity Study
ACUTE AND 28 DAYS REPEATED ORAL TOXICITY STUDY OF THE SIDDHA DRUG VEERA AYA CHENDHURAM (VAC)
12
Acute and 28 days repeated oral toxicity study of siddha drug gandhaga choornam on wistar albino rats
6
ACUTE AND 28 DAY REPEATED ORAL TOXICITY STUDY OF SIDDHA HERBOMINERAL FORMULATION LINGA MATHIRAI IN RATS
8
28-Day Repeated Oral Toxicity Study and Efficacy of a Siddha Polyherbal Formulation - Singinatha Choornam against Platelet Activating Factor-induced Rhinosinusitis in Wistar Albino Rat
6
ACUTE AND REPEATED ORAL TOXICITY OF SIDDHA METALLOMINERAL FORMULATION SEENA RASA CHENDURAM (SRC)
14
ACUTE AND 28 DAYS REPEATED ORAL TOXICITY STUDIES OF A SIDDHA DRUG PIRANDAI UPPU ON WISTAR ALBINO RAT
7
Acute toxicity and the 28 day repeated dose study of a Siddha medicine Nuna Kadugu in rats
13
B.26. SUB-CHRONIC ORAL TOXICITY TEST REPEATED DOSE 90 - DAY ORAL TOXICITY STUDY IN RODENTS
9
B.27. SUB-CHRONIC ORAL TOXICITY TEST REPEATED DOSE 90 - DAY ORAL TOXICITY STUDY IN NON-RODENTS
7
A 13 Week Repeated Oral Dose Toxicity Study of ChondroT in Sprague Dawley Rats
16
Repeated Dose Oral Toxicity Study of an Antidiabetic Polyherbal Formulation (Diapal Tablets) In Rats
10
Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral route in repeated dose study
11
Read-Across for Rat Oral Gavage Repeated-Dose Toxicity for Short-Chain Mono-Alkylphenols: A Case Study
55
Read-across of 90-day rat oral repeated-dose toxicity: A case study for selected n-alkanols
50
Acute and 26 Week Repeated Oral Dose Toxicity Study of UP446, a Combination of Scutellaria Extract and Acacia Extract in Rats
14
Read-across of 90-Day Rat Oral Repeated-Dose Toxicity: A Case Study for Selected 2-Alkyl-1-alkanols
66
Read-across of 90-day rat oral repeated-dose toxicity: A case study for selected 2-alkyl-1-alkanols
65
Assessment of acute, 14 day, and 13 week repeated oral dose toxicity of Tiglium seed extract in rats
12
Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats
9
Acute toxicity investigation regarding clinical and pathological aspects following repeated oral administration of iron oxide nanoparticles in rats
6